BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang SH. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer. Arch Pharm Res 2019;42:549-59. [DOI: 10.1007/s12272-019-01146-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen F, Li J, Wang H, Ba Q. Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment. Front Oncol 2021;11:746917. [PMID: 34722304 DOI: 10.3389/fonc.2021.746917] [Reference Citation Analysis]
2 Chen W, Qin Y, Liu S. CCL20 Signaling in the Tumor Microenvironment. Adv Exp Med Biol. 2020;1231:53-65. [PMID: 32060846 DOI: 10.1007/978-3-030-36667-4_6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Armstrong D, Chang CY, Lazarus DR, Corry D, Kheradmand F. Lung Cancer Heterogeneity in Modulation of Th17/IL17A Responses. Front Oncol 2019;9:1384. [PMID: 31921642 DOI: 10.3389/fonc.2019.01384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ma T, Zhang Y, Zhou X, Xie P, Li J. A Unique Role of T Helper 17 Cells in Different Treatment Stages of Multiple Myeloma. Clin Lymphoma Myeloma Leuk 2020;20:190-7. [PMID: 31980418 DOI: 10.1016/j.clml.2019.12.009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Costa AC, Santos JMO, Gil da Costa RM, Medeiros R. Impact of immune cells on the hallmarks of cancer: A literature review. Crit Rev Oncol Hematol 2021;168:103541. [PMID: 34801696 DOI: 10.1016/j.critrevonc.2021.103541] [Reference Citation Analysis]
6 Gu YY, Chen G, Lin P, Cheng JW, Huang ZG, Luo J, Zhai GQ, Wang YL, Yan HB, Li SH. Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma. Cancer Biomark 2020;27:265-75. [PMID: 31929144 DOI: 10.3233/CBM-191017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Moaaz M, Lotfy H, Motawea MA, Fadali G. The interplay of interleukin-17A and breast cancer tumor microenvironment as a novel immunotherapeutic approach to increase tumor immunogenicity. Immunobiology 2021;226:152068. [PMID: 33556742 DOI: 10.1016/j.imbio.2021.152068] [Reference Citation Analysis]
8 Lin Y, He Z, Ye J, Liu Z, She X, Gao X, Liang R. Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer. Onco Targets Ther 2020;13:13023-32. [PMID: 33376351 DOI: 10.2147/OTT.S278013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang M, Zhao H, Gao H. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. Viral Immunology. [DOI: 10.1089/vim.2021.0174] [Reference Citation Analysis]
10 de Sousa E, Lérias JR, Beltran A, Paraschoudi G, Condeço C, Kamiki J, António PA, Figueiredo N, Carvalho C, Castillo-Martin M, Wang Z, Ligeiro D, Rao M, Maeurer M. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery. Front Immunol 2021;12:592031. [PMID: 34335558 DOI: 10.3389/fimmu.2021.592031] [Reference Citation Analysis]
11 Lin B, Wang S, Yao Y, Shen Y, Yang H. Comprehensive co-expression analysis reveals TMC8 as a prognostic immune-associated gene in head and neck squamous cancer. Oncol Lett 2021;22:498. [PMID: 33981360 DOI: 10.3892/ol.2021.12759] [Reference Citation Analysis]
12 Kwiecień I, Rutkowska E, Sokołowski R, Bednarek J, Raniszewska A, Jahnz-różyk K, Rzepecki P, Domagała-kulawik J. Effector Memory T Cells and CD45RO+ Regulatory T Cells in Metastatic vs. Non-Metastatic Lymph Nodes in Lung Cancer Patients. Front Immunol 2022;13:864497. [DOI: 10.3389/fimmu.2022.864497] [Reference Citation Analysis]
13 Yu W, Hu J, Le H, Lu Y, Xu W, Yu W, Shen W. Tumstatin attenuates the promotion effect of IL-17 secreted by Th17 cells on the stemness maintenance of glioma cells. Pathol Res Pract 2021;223:153463. [PMID: 33971545 DOI: 10.1016/j.prp.2021.153463] [Reference Citation Analysis]
14 Mahaki H, Saeed Modaghegh MH, Nasr Isfahani Z, Amir Daddost R, Molaei P, Ahmadyousefi Y, Vahidzadeh M, Lotfiane E, Tanzadehpanah H. The Role of Peptide-Based Tumor Vaccines on Cytokines of Adaptive Immunity: A Review. Int J Pept Res Ther 2021;27:2527-42. [DOI: 10.1007/s10989-021-10270-4] [Reference Citation Analysis]
15 Zhou H, Zhang Z, Liu G, Jiang M, Wang J, Liu Y, Tai G. The Effect of Different Immunization Cycles of a Recombinant Mucin1-Maltose-Binding Protein Vaccine on T Cell Responses to B16-MUC1 Melanoma in Mice. Int J Mol Sci 2020;21:E5810. [PMID: 32823603 DOI: 10.3390/ijms21165810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Chen GG, Woo PYM, Ng SCP, Wong GKC, Chan DTM, van Hasselt CA, Tong MCF, Poon WS. Impact of metformin on immunological markers: Implication in its anti-tumor mechanism. Pharmacol Ther 2020;213:107585. [PMID: 32473961 DOI: 10.1016/j.pharmthera.2020.107585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Razavi AS, Mohtashami M, Razi S, Rezaei N. TGF-β signaling and the interaction between platelets and T-cells in tumor microenvironment: Foes or friends? Cytokine 2021;150:155772. [PMID: 34814016 DOI: 10.1016/j.cyto.2021.155772] [Reference Citation Analysis]
18 Liu H, Ji Y, Ma X, He A, Zhao W, Zhang P, Gu L, Lei B, Zhang Y, Wang Y, Zhang W, Wang J. Effects of CpG oligodeoxynucleotides on the differentiation of Treg/Th17 cells. Mol Immunol 2021;132:199-208. [PMID: 33454107 DOI: 10.1016/j.molimm.2021.01.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Principe N, Kidman J, Lake RA, Lesterhuis WJ, Nowak AK, McDonnell AM, Chee J. Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity? Front Oncol 2021;11:672747. [PMID: 33987104 DOI: 10.3389/fonc.2021.672747] [Reference Citation Analysis]
20 Chen X, Bi M, Yang J, Cai J, Zhang H, Zhu Y, Zheng Y, Liu Q, Shi G, Zhang Z. Cadmium exposure triggers oxidative stress, necroptosis, Th1/Th2 imbalance and promotes inflammation through the TNF-α/NF-κB pathway in swine small intestine. J Hazard Mater 2021;421:126704. [PMID: 34325292 DOI: 10.1016/j.jhazmat.2021.126704] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Man S, Hu L, Ji X, Wang Y, Ma Y, Wang L, Zhu J, Huang F. Risk of Malignancy and Tuberculosis of Biological and Targeted Drug in Patients With Spondyloarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials. Front Pharmacol 2021;12:705669. [PMID: 34776944 DOI: 10.3389/fphar.2021.705669] [Reference Citation Analysis]
22 Yi FS, Zhai K, Shi HZ. Helper T cells in malignant pleural effusion. Cancer Lett 2021;500:21-8. [PMID: 33309856 DOI: 10.1016/j.canlet.2020.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Mirshahi F, Aqbi HF, Isbell M, Manjili SH, Guo C, Saneshaw M, Dozmorov M, Khosla A, Wack K, Carrasco-Zevallos OM, Idowu MO, Wang XY, Sanyal AJ, Manjili MH, Bandyopadhyay D. Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma. Cell Rep 2022;38:110454. [PMID: 35235789 DOI: 10.1016/j.celrep.2022.110454] [Reference Citation Analysis]
24 Nutini A, Sohail A. Deep learning of the role of interleukin IL-17 and its action in promoting cancer. Bio-Algorithms and Med-Systems 2020;16:20200052. [DOI: 10.1515/bams-2020-0052] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Marques HS, de Brito BB, da Silva FAF, Santos MLC, de Souza JCB, Correia TML, Lopes LW, Neres NSM, Dórea RSDM, Dantas ACS, Morbeck LLB, Lima IS, de Almeida AA, Dias MRJ, de Melo FF. Relationship between Th17 immune response and cancer. World J Clin Oncol 2021; 12(10): 845-867 [PMID: 34733609 DOI: 10.5306/wjco.v12.i10.845] [Reference Citation Analysis]
26 Li Y, Wang J, Wang H, Zhang S, Wei Y, Liu S. The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer. Front Immunol 2022;13:850093. [DOI: 10.3389/fimmu.2022.850093] [Reference Citation Analysis]
27 Wu J, Luo D, Li S. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer. Breast Cancer (Dove Med Press) 2020;12:267-77. [PMID: 33324095 DOI: 10.2147/BCTT.S284076] [Reference Citation Analysis]
28 Hao F. Systemic Profiling of KDM5 Subfamily Signature in Non-Small-Cell Lung Cancer. Int J Gen Med 2021;14:7259-75. [PMID: 34737620 DOI: 10.2147/IJGM.S329733] [Reference Citation Analysis]
29 Zhang D, Li B, Zhao M. Therapeutic Strategies by Regulating Interleukin Family to Suppress Inflammation in Hypertrophic Scar and Keloid. Front Pharmacol 2021;12:667763. [PMID: 33959031 DOI: 10.3389/fphar.2021.667763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wu L, Yang FR, Xing ML, Lu SF, Chen HL, Yang QW, Zhang YT, Lu Y, Huang Y. Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma. Phytomedicine 2022;100:154055. [PMID: 35344716 DOI: 10.1016/j.phymed.2022.154055] [Reference Citation Analysis]
31 Niu Y, Zhou Q. Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion. Cell Mol Life Sci 2022;79:194. [PMID: 35298721 DOI: 10.1007/s00018-022-04227-z] [Reference Citation Analysis]
32 Chang S, Yin T, He F, Ding J, Shang Y, Yang J. CaMK4 promotes abortion-related Th17 cell imbalance by activating AKT/mTOR signaling pathway. Am J Reprod Immunol 2020;84:e13315. [PMID: 32738170 DOI: 10.1111/aji.13315] [Reference Citation Analysis]
33 Fang F, Zhang T, Li Q, Chen X, Jiang F, Shen X. The tumor immune-microenvironment in gastric cancer. Tumori 2022;:3008916211070051. [PMID: 35196917 DOI: 10.1177/03008916211070051] [Reference Citation Analysis]
34 Monteiro AC, Bonomo A. CD8+ T cells from experimental in situ breast carcinoma interfere with bone homeostasis. Bone 2021;150:116014. [PMID: 34022456 DOI: 10.1016/j.bone.2021.116014] [Reference Citation Analysis]
35 Yang X, Tian J, Ma B, Cao Q, Wu L, Chen J, Yang S, Su C, Duan X. Long-term aspirin intervention can inhibit TIGIT, regulating T cells to reverse damage to intestines. Biomed Pharmacother 2021;133:111028. [PMID: 33378943 DOI: 10.1016/j.biopha.2020.111028] [Reference Citation Analysis]
36 Karjalainen A, Shoebridge S, Krunic M, Simonović N, Tebb G, Macho-Maschler S, Strobl B, Müller M. TYK2 in Tumor Immunosurveillance. Cancers (Basel) 2020;12:E150. [PMID: 31936322 DOI: 10.3390/cancers12010150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
37 Galassi C, Musella M, Manduca N, Maccafeo E, Sistigu A. The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure. Cells 2021;10:2361. [PMID: 34572009 DOI: 10.3390/cells10092361] [Reference Citation Analysis]
38 Merz MP, Turner JD. Is early life adversity a trigger towards inflammageing? Exp Gerontol 2021;150:111377. [PMID: 33905877 DOI: 10.1016/j.exger.2021.111377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Chung KW, Cho YE, Kim SJ, Hwang S. Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis. Arch Pharm Res 2022. [PMID: 35391713 DOI: 10.1007/s12272-022-01379-1] [Reference Citation Analysis]